Hylomorph raised €4.7M in a Series B round in Sep 2023. The company is based in Zurich, Switzerland. Investors in the round: EFI Lake Geneva Ventures, Excellis Holding, Interconsult and 4 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
